COMP <GO>
CL vs PG // FORWARD P/E MULTIPLE
Colgate-Palmolive Company (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CL 6
— PG 9
▲ FORWARD P/E MULTIPLE LEADER: PG
LAST: $95.29 (+2.29%) • MKT CAP: $74.26B
forward-pe
32.4x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CL VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CL | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.10% | 51.20% | +8.90 | CL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 44.00% | 25.40% | +18.60 | CL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 16.2x | +3.30 | PG | /valuation <GO> |
| Free Cash Flow Yield | 4.42% | 3.77% | +0.65 | CL | /fcf-yield <GO> |
| Operating Margin | 16.20% | 24.30% | -8.10 | PG | /operating-margins <GO> |
| Net Profit Margin | 10.50% | 19.00% | -8.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 1.40% | 0.30% | +1.10 | CL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.90 | 5.59 | +1.31 | CL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.50% | +0.80 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 62.7 | -0.93 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.87 | +0.24 | CL | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 32.4x | 21.7x | +10.70 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $74.26B | $372.21B | -$297.95B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CL REV | PG REV | CL GROSS % | PG GROSS % | CL FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.38B | $84.28B | 60.1% | 51.2% | $3.28B | $14.04B |
| FY 2024 | $20.10B | $84.04B | 60.5% | 51.4% | $3.20B | $16.52B |
| FY 2023 | $19.46B | $82.01B | 44.0% | 44.0% | $2.87B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CL // BETA 1.11
PG // BETA 0.87